Monoclonal Gammopathy of Undetermined Significance (MGUS) Overview

Save information for later
Sign Up

Learn About Monoclonal Gammopathy of Undetermined Significance (MGUS)

What is the definition of Monoclonal Gammopathy of Undetermined Significance (MGUS)?
Monoclonal gammopathy of undetermined significance (MGUS) is a condition in which an abnormal protein called monoclonal protein is detected in the blood. MGUS typically does not cause any problems, although some affected people may experience numbness, tingling or weakness. In some cases, MGUS may progress over time to certain forms of blood cancer (such as multiple myeloma, macroglobulinemia, or B-cell lymphoma). MGUS is thought to be a multifactorial condition that is likely associated with the effects of multiple genes in combination with lifestyle and environmental factors. People with MGUS are usually monitored closely to ensure that the levels of monoclonal protein do not rise and other problems do not develop.
What are the alternative names for Monoclonal Gammopathy of Undetermined Significance (MGUS)?
  • Monoclonal gammopathy of undetermined significance
  • MGUS
Who are the top Monoclonal Gammopathy of Undetermined Significance (MGUS) Local Doctors?
Prashant Kapoor
Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology | Oncology | Hematology Oncology
Elite in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology | Oncology | Hematology Oncology

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
Languages Spoken:
English, Hindi
Accepting New Patients
Offers Telehealth

Prashant Kapoor is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Kapoor is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Waldenstrom Macroglobulinemia, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Kapoor is currently accepting new patients.

Demet G. Yasar
Distinguished in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Distinguished in Monoclonal Gammopathy of Undetermined Significance (MGUS)

Vince Lombardi Cancer Clinic

2845 Greenbrier Rd, Ste 250, 
Green Bay, WI 
Languages Spoken:
English
Offers Telehealth

Demet Yasar is a Hematologist in Green Bay, Wisconsin. Dr. Yasar is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS).

 
 
 
 
Learn about our expert tiers
Learn More
Mohammed A. Raheem
Distinguished in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology | Oncology
Distinguished in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Hematology | Oncology

Advocate Infusion Center

1221 N Highland Ave 1st Fl, 
Aurora, IL 
Languages Spoken:
English

Mohammed Raheem is a Hematologist and an Oncologist in Aurora, Illinois. Dr. Raheem is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

What are the latest Monoclonal Gammopathy of Undetermined Significance (MGUS) Clinical Trials?
CHAAMP (Charlotte African American MGUS Project) Internal Pilot Study

Summary: The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION-3) Study

Summary: The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substa...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Monoclonal Gammopathy of Undetermined Significance (MGUS)?